Buyers are responsible for ensuring that procurement, storage, handling, and use of this product comply with all applicable federal and state regulations, including those governing the purchase and use of prescription pharmaceutical products
At RevIVe Mobile IV Therapy, we believe in transparent pricing with no hidden fees
That signal is preclinical only : Dihexa has never entered a human clinical trial, several of the foundational mechanism papers were retracted in 2025 for falsified/fabricated data [4] , and everything below reflects animal reference data and community conventions provided strictly for research and educational reference not medical advice or a recommendation to self-administer
Research demonstrates that GHK-Cu influences gene expression patterns to favor tissue repair over inflammatory damage, downregulating pro-inflammatory cytokines while upregulating protective factors including antioxidant enzymes and tissue repair mediators
Standard human dosing protocols based on animal studies suggest 0.25-0.5 mg daily via subcutaneous injection for 4-8 weeks
doi: 10.3389/fimmu.2022.833355 262 SinhaR.SinhaI.CalcagnottoA.TrushinN.HaleyJ
